Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery

Launched by GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL · Aug 13, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how well different surgical treatments work for patients who develop tricuspid valve regurgitation after having heart surgery. Tricuspid valve regurgitation happens when the valve in the heart does not close properly, which can lead to complications. The researchers want to understand the outcomes of the surgeries performed at their center over the past 25 years, helping to improve future care for patients.

To participate in this trial, individuals need to be between 58 and 43 years old and have had surgery for tricuspid valve issues after heart surgery from 1999 to 2023. Unfortunately, younger patients under 16, those with severe cases due to primary pulmonary hypertension, and patients with missing medical information cannot join. Participants can expect to share their experiences and outcomes, which will contribute to a better understanding of how these surgical treatments work over time. This trial is currently recruiting new participants, and it's a great opportunity to help advance knowledge in this area of heart health.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria:patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery
• • Exclusion Criteria: age \<16，severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.